6:14 PM
 | 
Dec 05, 2012
 |  BC Extra  |  Politics & Policy

Pricing negotiations under AMNOG completed for 12 drugs

Germany's Statutory Health Insurance Funds Association (GKV-Spitzenverband) said pricing negotiations under drug pricing law AMNOG have been completed for 12 drugs. For 11 drugs, GKV-Spitzenverband and drug sponsors reached an agreement on a price; the price for ophthalmic drug Yellox bromenfac from Bausch + Lomb Inc. (Rochester, N.Y.) was determined through independent arbitration. GKV-Spitzenverband did not disclose...

Read the full 272 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >